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The direct impact of osteoarthritis (OA) in real life settings has 
been poorly studied on large population. However, this informa- 
tion is essential to identify the burden of the disease. 
Methods: In 2000, a nation-wide survey of more than 5000 physi- 
cians, either general practitioners (90.3%) or rheumatologists 
(9.7%), representative of the French medical demography, was 
conducted. Each recruited the first two patients consulting for 
hip, knee or hand OA after the onset of the survey, and asked 
them to complete a questionnaire about activities of daily living. 
Results: Clinical and social information was available for 10412 
OA patients, mean age 66.2 ±10.2 years, sex ratio (F :M) 1.96. For 
84.5% of them, OA diagnosis was based on both clinical and 
radiographic findings. 69.2% of the respondents were retired, 
17.4% were workers, 10.2% unpaid household workers, and 3.2 
unemployed or on permanent disability. 
Limitation in activities of daily living 81.5% 
grocery shopping 57.3% personal care 10.5% 
house cleaning 43.0% meal preparation 10.2% 
dressing 21.5% other 14.2% 
Modification of activities 76.9% 
gardening 47.9% sports 20.8% 
odd jobs around the 
house 22.8% other 16.5% 
Mobility problems 61.9% 
outside 98.8% at home 20.7% 
Workers (17.4%) 
limitation in their 64.4% missed work 21.6% 
professional activity 
These limitations induced expenditures not covered by public or 
private health care insurance for 20.4% of the respondents, main- 
ly related to moving (10.5%), house keeping (9.5%) and grocery 
delivery (8.1%). 
Conclusion: This study provides representative data about the 
functional impact of OA in daily life settings. It shows significant 
impact of OA-relate disability in retired people as well as those 
involved in labor market activities. 
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PROTECTIVE EFFECT OF THE CHONDROPROTECTIVE 
AGENTS GLUCOSAMINE HCL AND CHONDROITIN SULFATE 
(COSAMIN®DS) ON ARTICULAR CARTILAGE EXPOSED TO 
NONSTEROIDAL ANTI- INFLAMMATORY AGENTS 
L Lippiello, M Sung, T Henderson 
Nutramax® Laboratories ~no., Edgewood, MD, USA 
These studies evaluated the ability of a combination of "chon- 
droprotective" agents, glucosamine HCI (Gin), and chondroitin 
sulfate (CS) with manganese ascorbate (MnAs) (Cosarnin® DS, 
Nutrainax® Labs Inc., Edgewood, MD.) to protect articular carti- 
lage from the potentially adverse metabolic effects of nons- 
teroidal anti-inflammatory agents (NSAIDs). Articular cartilage 
explant and high-density monolayer cultures were assayed for 
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proteoglycan (PG) synthesis and degradation following timed 
exposure to therapeutic dosages of NSAIDs. A time-dependent 
comparison was made of the cartilage response to NSAIDs in tis- 
sues from young (15 months) steers and aged (7-10 years) 
Holsteins. 
Methods: Cartilage explants and high-density monolayer cul- 
tures were cultured to a metabolic steady state prior to exposure 
to the NSAIDs etodolac, celecoxib, aspirin and indomethacin. PG 
synthesis into the cell layer or explant was monitored at 8, 24 and 
144 hours by pulse labeling with 35 SO 4 . PG degradation was 
assayed by counting radioactivity released into the media over a 
24-hour period from 35 SO 4 prelabeled cultures. Statistical sig- 
nificance was determined by the KruskaI-Wallis nonparametric 
analysis of variance. 
Results: A dose-dependent stimulated of monolayer cultures by 
a combination of Gin, CS and MnAs was apparent within 5 hours 
of exposure, in contrast, explants required at least 24 hours for up 
regulation of synthetic activity which was inversely related to 
dose. Cosamin®DS clearly eliminated etodolac and celecoxib- 
induced inhibition of cartilage synthetic activity in tissue from 
aged animals. Similarly, in aged animals etodolac but not cele- 
coxib increased PG breakdown which was prevented by simulta- 
neous exposure to Cosamin® DS. lndomethacin had little effect 
at 10 ug/ml while aspirin stimulated synthetic activity in aged tis- 
sue by 40% after 72 and 144 hours exposure..Addition of 
Cosamin® DS slightly augmented this response. 
Conclusions: In vitro, cartilage matrix does not appear to be an 
impenetrable barrier to CS, one of the components of Cosamin® 
DS. The inverse relationship between Cosainin® DS dose and 
level of up regulation may have clinical significance. In summary, 
this combination of agents may be useful adjunct therapy for 
preservation of articular cartilage by counteracting the adverse 
metabolic effects of NSAIDs, 
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Aim: To investigate the long-term effects (12 days) of 
avocado/soybean unsaponifiable (ASU; 1 part avocado and 2 
parts soybean, Piascledine, Pharmascience-Expanscience, 
Courbevoie, France) mixture on the metabolism of human chon- 
drocytes cultured in alginate beads. 
Method: Enzymatically isolated 5steoarthritic (OA) chondrocytes 
were cultured in alginate beads in a well-defined culture medium 
for 12 days. The DNA content was measured according to a flu- 
orimetric method. Interleukin-6 and -8 (IL-6, IL-8), stromelysin 
(MMP-3) and aggrecan (AGG) productions were assayed by spe- 
cific enzyme amplified sensitivity immunoassays (EASIA), and 
prostaglandin E 2 (PGE2) production by a specific radioim- 
munoassay. 
Results: In the basal conditions, ASU at 10 Xg/mt, increased by 
35 % the AGG contained in the alginate beads. Furthermore, ASU 
significantly inhibited IL-6, IL-8 and MMP-3 syntheses. IL-lb 
stimulated IL-6, IL-8, PGE 2 and MMP-3 productions and fully 
blocked AGG synthesis. When it was added simultaneously with 
IL-1, ASU partially reversed the IL-l~-stimulatory effect on 11--6, 
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11.-8, PGE 2 and MMP-3 productions but did not modify the AGG 
inhibition. Nevertheless, ASU promoted the restoration of AGG 
synthesis after a 3-days pre-treatment with IL-113, 
Conclusion: From this work, we can conclude that ASU shows 
anti-inflammatory properties by inhibiting PGE 2, IL-6 and IL-8. 
Furthermore, it stimulates AGG production and accumulation i
the extracellular matrix and promotes matrix formation after IL-113 
treatment. In parallel, it decreases MMP-3 production in both 
untreated and IL-ll3-treated cultures. Taken together, these 
results suggest that ASU could have a structural effect in OA by 
decreasing matrix degradation and restoring its formation. 
This work was supported by an unrestricted educational grant 
from Pharmasciences laboratories. 
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LONG-TERM EFFECT OF MULTIPLE COURSES OF INTRA- 
ARTICULAR INJECTIONS OF SODIUM HYALURONAN 
DURING THE DEVELOPMENT OF OSTEOARTHRtTIS 
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Aim: Effects of hyaluronan (HA) therapy on disease progression is 
of clinical interest. While the half-life of HA is short (hours), the 
duration of pain relief can be more than 1 year. Several in vivo ani- 
mal studies have reported on early term effectiveness of HA treat- 
ment on experimentally induced osteoarthritis (OA). Because of 
the reported half-life, a question arose regarding the effectiveness 
of this treatment during the development of OA over the long 
term. Our purpose is to carry out a controlled long-term study 
and compare a sequential series of intra-articular injections of HA 
(Hyalgan®: MW 5-7.3 X 105 daltons) to a single series during the 
development of OA. 
Methods: Fifty mature New Zealand white rabbits with closed 
epiphysis (five groups of 10 animals each) had their femoral 
condyle and tibial plateau assessed at 26 weeks post surgical 
development of OA. Group 1 had only their ACL transected 
(ACL'r). Group 2 had a single series of 5 intra-articular HA injec- 
tions 4 weeks post ACLT. Group 3 had a single series of HA vehi- 
cle (saline phosphate buffer (PBS)) injections 4 weeks post ACLT. 
Group 4 had a sequential series of 5 injections of HA at 4 and 13 
weeks post ACLT. Group 5 had a sequential series of 5 injections 
of HA vehicle (PBS) at 4 and 13 weeks post ACLT. All animals 
were sacrificed at 26 weeks and graded as follows: Grade 1 intact 
surface; Grade 2 minima/fibrillation; Grade 3 overt fibrillation; 
Grade 4a 0ram <erosion < 2mm; Grade 4b 2ram <erosion <5ram; 
and Grade 4c 5mm <erosion. 
Results: All groups had severe articular degradation of the 
femoral condyle cartilage. There was a slight benefit of intra-artic- 
ular injections of PBS (Group 3) compared with the ACLT Group 
1. The 5XHA/4weeks (Group 2) and sequential injections 
10XHA/4weeks (Group 4) seemed to elicit a slight benefit on pre- 
venting degradation of cartilage. On the tibial plateau, repeat 
courses of HA (Group 4) reduced the degree of articular cartilage 
degradation when compared with all treatment groups. 
Conclusions: Multiple courses of HA treatment may be able to 
modify the disease progression of OA of the knee, and may be 
useful in long-term management. 
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A PROSPECTIVE STUDY 
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Aim: To confirm the risk factors (RF) of HOA and their possible 
associations. Is there still room for primary (prim) HOA? 
Method: All new out-patients (lots) with HOA (ACR criteria) were 
screened for the following RF: 1. Congenital dysplasia (measured 
with femorocoxometer). 2. Acetabular protrusio. 3. Tilt defor- 
mity. 4. Coxa plana. 5. Familial clustering (Faro clust) for HOA 
(first degree relatives). 6. Sport: at least 10 years of practice with 
competition in soccer, rugby, tennis, basket ball, handball, judo, 
karate, long distance running. 7. Hip hypersollicitation at work 
(hard work): more than 15 years with heavy loads. 8. Trauma. 9. 
Femoral head necrosis. For each: sex, age at onset of pain, side 
(s) involved and weight 
Results: Out of 66 pts, 30 had bilateral HOA, 42 were females 
(63%), 6 were overweight. Age at onset: 54+16.1 years. Main RF: 
I-SPORT: 20 pts (30%), of whom 12(18%) (age:47± 12.8 years) 
had no other RF and 8 had associated RF i.e. Fam-Clust 5 pts, 
dysplasia 2, trauma 1. II-DYSPLASIA: 14 (2 1%) ; with no other 
RF: 11 (age 46±12.6). Ill- FAM CLUST (dysplasia excluded as 
hereditary by itself): 11 (t6.6%), of whom 5(7.6%) had no other 
RE IV-Rarer conditions: protrusio 3, hard work 2, trauma 2, necro- 
sis 2. V Tilt deformity (5pts) was present only in sportsmen. 
Conclusion: Two 'new' RF prevail : sport (the only RF in 18%) 
and fam-clust (the only RF in 7.5%). Dysplasia is still present (the 
only RF in 16.6%)Out of 66 pts, 9 have association of 2 RE There 
remain 14 pts (2 1%) without any RE It may be said also that prim 
HOA accounts for 19 pts (29%), of whom 5 with Fam Clust (age: 
64+1). 
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WHAT CONSTITUTES CHANGE IN RESPONSE TO 
INTERVENTIONS FOR OSTEOARTHRITIS? 
R Campbell, B Quilty, P Dieppe 
MRC HSRC, Bristol, UK 
Aim: To compare changes in pain and disability recorded by the 
WOMAC with those reported by patients during in-depth inter- 
views. 
Methods: As part of a trial of the effects of a package of phys- 
iotherapy for the treatment of patello-femoral osteoarthritis (OA) 
a nested qualitative study of 20 of the participants was under- 
taken. WOMAC was used as the primary outcome measure in 
the trial and was recorded immediately before and 5 months 
after the intervention. Semi-structured in-depth interviews with 
the 20 patients were carried out approximately 3 months after 
the intervention. They were tape-recorded, transcribed and 
analysed by two independent observers, who were blind to the 
quantitative data. The qualitative and quantitative data were 
then compared. 
Results: WOMAC data indicated that pain was better in 14 
patients, worse in 3 and unchanged in 3. For disability, improve- 
ment was seen in 7, no change in 6 and worsening in 7. In con- 
trast, data from the qualitative interviews indicated that only one 
patient thought e was worse (either for pain or disability), 6 
thought here were about the same or were unsure and the 
remaining 13 considered themselves better. There were some 
marked discrepancies between the two sorts of data, some 
patients who showed worsening on WOMAC scores considering 
themselves to be much better and vice-versa. 
